Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jonas Bäckström"'
Autor:
Peter Juhasz, Björn Glinghammar, Jonas Bäckström, Shunghuang Wang, Ina Schuppe-Koistinen, Lars I. Nord, Maritha Marcusson-Ståhl, Johan Kolmert, Raji Balasubramanian, Steve Martin, Chenhui Zeng, Ulf Andersson, Kerstin Nilsson, Karin Cederbrant, Mira Hannula, Johan Lindberg
Publikováno v:
Biomarkers. 14:572-586
Ximelagatran was developed for the prevention and treatment of thromboembolic conditions. However, in long-term clinical trials with ximelagatran, the liver injury marker, alanine aminotransferase (ALT) increased in some patients. Analysis of plasma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfcc57f4f7fc73438676a4dd7b2d318e
https://doi.org/10.3109/13547500903261354
https://doi.org/10.3109/13547500903261354
Autor:
Guy L. Reed, Vinay Bhal, Lisa K. Jennings, Henry E. Speich, Jonas Bäckström, Kourtney H. Houser, Alex T. Caughran, Aiilyan K. Houng, Malin Enerbäck, Lindsey T. Lands
Publikováno v:
Journal of cardiovascular pharmacology. 63(6)
P2Y(12) receptor antagonism inhibits platelet aggregation by preventing adenosine diphosphate (ADP)-mediated amplification of activation pathways downstream of primary agonists, such as thrombin and collagen. However, the role of ADP signaling in mai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c959b1a1998067d60e6c620ed228999d
https://pubmed.ncbi.nlm.nih.gov/24477045
https://pubmed.ncbi.nlm.nih.gov/24477045
Autor:
Ulrika Logren, Henrik Svennberg, Martin Ahnoff, Kristina Dunér, Jonas Bäckström, Niklas Magnell
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 852(1-2)
An analytical method was developed for the determination of ximelagatran, an oral direct thrombin inhibitor, its active metabolite melagatran, and the two intermediate metabolites, OH-melagatran and ethyl-melagatran in human plasma. Extraction of pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d74d8916f493ff45f34c4eade0fb0343
https://pubmed.ncbi.nlm.nih.gov/17296338
https://pubmed.ncbi.nlm.nih.gov/17296338
Autor:
Andersson, Ulf1 (AUTHOR) ulf.s.andersson@astrazeneca.com, Lindberg, Johan1 (AUTHOR), Wang, Shunghuang2 (AUTHOR), Balasubramanian, Raji3 (AUTHOR), Marcusson-Ståhl, Maritha1 (AUTHOR), Hannula, Mira1 (AUTHOR), Zeng, Chenhui2 (AUTHOR), Juhasz, Peter J.2 (AUTHOR), Kolmert, Johan1 (AUTHOR), Bäckström, Jonas1 (AUTHOR), Nord, Lars1 (AUTHOR), Nilsson, Kerstin4 (AUTHOR), Martin, Steve2 (AUTHOR), Glinghammar, Björn1 (AUTHOR), Cederbrant, Karin1 (AUTHOR), Schuppe-Koistinen, Ina1 (AUTHOR)
Publikováno v:
Biomarkers. Dec2009, Vol. 14 Issue 8, p572-586. 15p. 1 Diagram, 3 Charts, 3 Graphs.
Autor:
Matsson, Elin M., Eriksson, Ulf G., Knutson, Lars, Hoffmann, Kurt-Jürgen, Logren, Ulrika, Fridblom, Patrik, Petri, Niclas, Lennernäs, Hans
Publikováno v:
Journal of Clinical Pharmacology; 05/01/2011, Vol. 51 Issue 5, p770-783, 14p